upadacitinib
abbvie
[' upa ', 'crohn']
data on upa in crohn s disease from clinical trials demonstrate efficacy in patients who were biologic exposed with the following caveats: possible signal for decrease response in those with prior tnf failure upa 30mg daily &gt; upa 15 mg daily for maintenance #ecco23 
Gastroenterologist with a focus on Inflammatory Bowel Disease @UCSF II Alum @UCSF, @Yale, @montefioreNYC